Literature DB >> 29067118

Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition.

Ping Gong1, Fang Deng2, Wei Zhang3, Jin Ji1, Jia Liu1, Yinan Sun1, Jiayu Hu1.   

Abstract

Tectorigenin is a plant isoflavonoid primarily derived from the flowers of Pueraria thomsonii Benth. Although various biological properties of tectorigenin have been reported, such as its antioxidant activity, the effects of tectorigenin on the cellular models of Parkinson's disease have not yet been elucidated. The aims of the current study were to investigate whether tectorigenin prevents neurotoxicity induced by MPP+ (also known as 1-methyl-4-phenylpyridinium) in SH-SY5Y cells and to elucidate the underlying protective mechanism. Cell viability and lactate dehydrogenase release were measured. The morphological changes of apoptotic cells were observed by Hoechst 33258 staining. Caspase-3, superoxide dismutase, catalase and glutathione peroxidase activity was measured using commercially available ELISA kits. The expression of cytochrome c, Bax, Bcl-2 and NADPH oxidase were detected by western blot analysis. The results indicated that treatment with MPP+ causes a significant decrease in the viability of cells and an increase in apoptosis, as evidenced by the upregulation of apoptotic cells, caspase-3 activity and cytochrome c expression. By contrast, these effects were all reversed by pretreatment with tectorigenin in SH-SY5Y cells. Tectorigenin also inhibited the MPP+-induced changes of Bax and Bcl-2 levels. In addition, pretreatment with tectorigenin mitigated the MPP+-caused increases in the levels of reactive oxygen species and NADPH oxidase protein in SH-SY5Y cells. Simultaneously, tectorigenin abolished the downregulation of antioxidant enzymes, including superoxide dismutase, catalase and glutathione peroxidase, that was induced by MPP+. In conclusion, the present study data indicate that the neuroprotective effect of tectorigenin against MPP+-induced cytotoxicity and apoptosis may be involved in attenuating oxidative stress and enhancing antioxidant defense.

Entities:  

Keywords:  MPP+; Parkinson's disease; neurotoxicity; oxidative stress; tectorigenin

Year:  2017        PMID: 29067118      PMCID: PMC5647714          DOI: 10.3892/etm.2017.5049

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

Review 1.  The pathology of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Adv Neurol       Date:  2001

2.  In vitro evaluation of tectoridin, tectorigenin and tectorigenin sodium sulfonate on antioxidant properties.

Authors:  Ting Han; Gang Cheng; Ying Liu; Hong Yang; Yu-Tao Hu; Wen Huang
Journal:  Food Chem Toxicol       Date:  2011-11-04       Impact factor: 6.023

3.  Use of lactate dehydrogenase release to assess changes in culture viability.

Authors:  A J Racher; D Looby; J B Griffiths
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

Review 4.  [Oxidative stress and Parkinson's disease: mechanisms and perspectives of treatment].

Authors:  E A Katunina; N V Titova; E A Malykhina; M G Gasanov; A A Makarova; T A Voronina; L N Nerobkova; E A Valdman; G N Avakyan
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2015

5.  Protective effects of puerariaeflos against ethanol-induced apoptosis on human neuroblastoma cell line SK-N-MC.

Authors:  M H Jang; M C Shin; Y J Kim; J H Chung; S V Yim; E H Kim; Y Kim; C J Kim
Journal:  Jpn J Pharmacol       Date:  2001-12

Review 6.  Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease.

Authors:  Peter J Houghton; Melanie-Jayne Howes
Journal:  Neurosignals       Date:  2005

7.  Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro.

Authors:  K T Lee; I C Sohn; D H Kim; J W Choi; S H Kwon; H J Park
Journal:  Arch Pharm Res       Date:  2000-10       Impact factor: 4.946

8.  Passive cutaneous anaphylaxis-inhibitory action of tectorigenin, a metabolite of tectoridin by intestinal microflora.

Authors:  Eun-Kyung Park; Yong-Wook Shin; Hae-Ung Lee; Chang Soo Lee; Dong-Hyun Kim
Journal:  Biol Pharm Bull       Date:  2004-07       Impact factor: 2.233

Review 9.  Mitochondrial Dysfunction in Parkinson's Disease.

Authors:  Hyo Eun Moon; Sun Ha Paek
Journal:  Exp Neurobiol       Date:  2015-06-08       Impact factor: 3.261

Review 10.  Oxidative stress and Parkinson's disease.

Authors:  Javier Blesa; Ines Trigo-Damas; Anna Quiroga-Varela; Vernice R Jackson-Lewis
Journal:  Front Neuroanat       Date:  2015-07-08       Impact factor: 3.856

View more
  5 in total

1.  Citronellol Prevents 6-OHDA-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Parkinson Disease Model of SH-SY5Y Cells via Modulating ROS-NO, MAPK/ERK, and PI3K/Akt Signaling Pathways.

Authors:  Jiahui Shao; Xuan Liu; Mengjia Lian; Youbing Mao
Journal:  Neurotox Res       Date:  2022-09-12       Impact factor: 3.978

2.  MiR-19b alleviates MPP+-induced neuronal cytotoxicity via targeting the HAPLN4/MAPK pathway in SH-SY5Y cells.

Authors:  Wei Liu; Lijiao Geng; Yong Chen
Journal:  RSC Adv       Date:  2018-03-16       Impact factor: 4.036

3.  Cerebroventricular Injection of Pgk1 Attenuates MPTP-Induced Neuronal Toxicity in Dopaminergic Cells in Zebrafish Brain in a Glycolysis-Independent Manner.

Authors:  Cheng-Yung Lin; Hsiang-Chien Tseng; Yu-Rong Chu; Chia-Lun Wu; Po-Hsiang Zhang; Huai-Jen Tsai
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

4.  Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model.

Authors:  Saumitra Sen Singh; Sachchida Nand Rai; Hareram Birla; Walia Zahra; Aaina Singh Rathore; Hagera Dilnashin; Richa Singh; Surya Pratap Singh
Journal:  Oxid Med Cell Longev       Date:  2020-05-27       Impact factor: 6.543

5.  Use of Chinese Herbal Medicines Is Related to a Reduction in Depression Risk Among Patients With Insomnia: A Matched Cohort Study.

Authors:  Yun-Wen Chiao; Hanoch Livneh; How-Ran Guo; Wei-Jen Chen; Ming-Chi Lu; Miao-Chiu Lin; Chia-Chou Yeh; Tzung-Yi Tsai
Journal:  Front Neurol       Date:  2021-01-20       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.